Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation

Brain Research

Volumn 1106, Issue 1, 2006, Pages 12-20

  Khundakar, A A ^a   Zetterstrom T S C ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Antidepressant drugs; Brain derived neurotrophic factor (BDNF); Electroconvulsive shock (ECS); Hippocampus; Transcripts

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DESIPRAMINE; FLUOXETINE; MESSENGER RNA; MONOAMINE OXIDASE INHIBITOR; OLIGONUCLEOTIDE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRIC SHOCK; EXON; GENE; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; DESIPRAMINE; DRUG ADMINISTRATION SCHEDULE; ELECTROSHOCK; EXONS; FLUOXETINE; GENE EXPRESSION REGULATION; MALE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANYLCYPROMINE; UP-REGULATION;

EID: 33746734172     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.063     Document Type: Article

References (31)

1. Altieri M., Marini F., Arban R., Vitulli G., and Jansson B.O. Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res. 1000 (2004) 148-155
2. Blier P. Possible neurobiological mechanisms underlying faster onset of antidepressant action. J. Clin. Psychiatry 62 (2001) 7-11
3. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 (2001) 260-265
4. Clayton D.F. The genomic action potential. Neurobiol. Learn. Mem. 74 (2000) 185-216
5. Cole A.J., Abu-Shakra S., Saffen D.W., Baraban J.M., and Worley P.F. Rapid rise in transcription factor mRNAs in rat brain after electroshock-induced seizures. J. Neurochem. 55 (1990) 1920-1927
6. Conti A.C., Cryan J.F., Dalvi A., Lucki I., and Blendy J.A. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J. Neurosci. 22 (2002) 3262-3268
7. Coppell A.L., and Zetterström T.S.C. Acute 5-HT4 receptor-mediated regulation of BDNF mRNA by fluoxetine in the rat hippocampus. Eur. J. Neurosci. 12 (2000) 17
8. Coppell A.L., Pei Q., and Zetterström T.S.C. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2003) 903-910
9. de Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., Murray T.K., Gaillard J.P., Deville C., Xhenseval V., Thomas C.E., O'Neill M.J., and Zetterström T.S.C. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
10. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatment in the adult rat brain. Neuropharmacology 45 (2003) 553-563
11. Gartside S.E., Umbers V., Hajos M., and Sharp T. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115 (1995) 1064-1070
12. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109 (2002) 143-148
13. Khundakar A.A., and Zetterström T.S.C. Differential expression BDNF exons in rat brain after systemic administration of paroxetine and tranylcypromine. Br. J. Pharmacol. 137 (2002) 122
14. Khundakar A.A., Mazumdar A., and Zetterström T.S.C. Gene expression for brain derived neurotrophic factor in rat hippocampus is reduced by baclophen, tranylcypromine and paroxetine but not flunitrazepam. Br. J. Pharmacol. 136 (2002) 57
15. Kokaia Z., Metsis M., Kokaia M., Bengzon J., Elmer E., Smith M.L., Timmusk T., Siesjo B.K., Persson H., and Lindvall O. Brain insults in rats induce increased expression of the BDNF gene through differential use of multiple promoters. Eur. J. Neurosci. 6 (1994) 587-596
16. Lauterborn J.C., Rivera S., Stinis C.T., Hayes V.Y., Isackson P.J., and Gall C.M. Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. J. Neurosci. 16 (1996) 7428-7436
17. Lindefors N., Brodin E., and Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience. 65 (1995) 661-670
18. Metsis M., Timmusk T., Arenas E., and Persson H. Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8802-8806
19. Morgan J.I., Cohen D.R., Hempstead J.L., and Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237 (1987) 192-197
20. Morinobu S., Strausbaugh H., Terwilliger R., and Duman R.S. Regulation of c-Fos and NGF1-A by antidepressant treatment. Synapse 25 (1997) 313-320
21. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
22. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
23. Pei Q., Burnett P.W.J., Grahame-Smith D.G., and Zetterström T.S.C. Differential effects of acute and chronic electroconvulsiveshock on the gene expression of voltage-activated potassium channel subunits in the rat brain. Neuroscience 78 (1996) 343-350
24. Russo-Neustadt A.A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
25. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., and Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 54 (2003) 70-75
26. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22 (2002) 3251-3261
27. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56 (1997) 131-137
28. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20 (1998) 709-726
29. Timmusk T., Palm K., Metsis M., Reintam T., Paalme V., Saarma M., and Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10 (1993) 475-489
30. Zetterström T.S.C., Pei Q., and Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Mol. Brain Res. 57 (1998) 106-110
31. Zetterström T.S.C., Pei Q., Madhav T.R., and Grahame-Smith D.G. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38 (1999) 1063-1073